The University of Texas MD Anderson Cancer Center launched its Institute for Cell Therapy Discovery & Innovation.Â
Nicole D. Fleming has joined Fred Hutch Cancer Center as the new deputy chief medical officer. Fleming brings expertise as a doctor, surgeon, researcher, administrator, mentor, and mother of three school-age children that fits well with the mission of a recently merged organization coping with growing pains.
NCI renewed the Comprehensive Cancer Center designation to the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, awarding it a five-year, $14.2 million grant.
Melissa L. Fishel was named the Myles Brand Scholar in Cancer Research by Indiana University Melvin and Bren Simon Comprehensive Cancer Center. Fishel is a tumor cell biologist working toward new targets and treatments for pancreatic cancer.
Nasser H. Hanna, an IU Health physician and the Tom and Julie Wood Family Foundation Professor of Lung Cancer Clinical Research at Indiana University School of Medicine and Indiana University Melvin and Bren Simon Comprehensive Cancer Center, was named the screening program director at IU Health.
J. Leonard Lichtenfeld joined SpotitEarly, an Israel-based technology company transforming cancer screening by harnessing the power of artificial intelligence and dogs to detect cancer early, as chief medical officer.Â
Marina Konopleva, director of the Leukemia Program and co-director of the Blood Cancer Institute at the Montefiore Einstein Comprehensive Cancer Center, has joined Break Through Cancer, a collaborative medical research foundation that supports teams of scientists as they advance treatments for some of the world’s deadliest cancers.Â
LSU Health New Orleans was awarded a five-year, $3.1 million grant from the National Institute of Dental and Craniofacial Research.
Fred Hutchinson Cancer Center received a $2 million gift from philanthropists Bob and Pat Herbold to create the Bob and Pat Herbold Computational Biology Endowed Chair.Â
Six Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium scientists received $1.7M in grants from Breast Cancer Research Foundation to launch or continue studies aimed at improving outcomes in breast cancer.
